What analyst predict for Veru Inc NASDAQ:VERU ?


What analyst predict for Veru Inc NASDAQ:VERU ?

Veru Inc headquartered in Chicago, Illinois, United States is reporting their earnings on 12/13/2018 after the bell. Street forecast for the quarter ending Sep 2018 is $-0.09.

According to stock market daily analyst this is Lower then same time previous year.Veru Inc, reported EPS for the same quarter last year was $-0.1.



About Veru Inc NASDAQ:VERU

Veru is the new company that is a result of the acquisition of Aspen Park Pharmaceuticals by The Female Health Company.

Veru is a biopharmaceutical company focused on urology and oncology. Veru utilizes FDA’s 505(b)(2) regulatory approval pathway to develop and commercialize drug candidates. FDA’s 505(b)(2) regulatory approval pathway is designed to allow for potentially expedited regulatory approval based on a previously established safety and efficacy profile of the product. Veru is developing products under the 505(b)(1) pathway as well, which is the traditional new drug application (NDA) pathway. The company is currently developing drug product candidates for benign prostatic hyperplasia (BPH or enlarged prostate), hot flashes associated with prostate cancer hormone treatment, male infertility and novel oral chemotherapy (alpha & beta tubulin inhibitor) for a variety of malignancies, including metastatic prostate, breast and ovarian cancers.

Veru markets and sells the FC2 Female Condom® (now available by prescription in the US including through the virtual doctor smartphone app “HeyDoctor” at www.fc2.us.com) and PREBOOST® medicated individual wipe, which is a male genital desensitizing drug product for the prevention of premature ejaculation. The company’s division, The Female Health Company, is focused on the global public health sector FC2 business. This division markets the company’s Female Condom (FC2) to entities, including ministries of health, government health agencies, U.N. agencies, nonprofit organizations and commercial partners, that work to support and improve the lives, health and well-being of women around the world.

% Change
Market Cap
% Change from 52 Week Low
% Change from 52 Week High
Shares Outstanding
Dividend Rate